Skip to main content

Advertisement

Log in

p21/waf1 and smooth-muscle actin α expression in stromal fibroblasts of oral cancers

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 01 October 2011

Abstract

Background

Concerted alterations between stromal fibroblasts and neoplastic cells underline the carcinogenic process. Activation of alpha-smooth muscle actin (SMA) expression, a cytoskeleton protein normally expressed only in myoepithelial cells, is considered a landmark for the activation of stromal fibroblasts with little however being known regarding the mechanism governing the expression of SMA in the stroma.

Methods

We have evaluated by immunohistochemistry the expression of SMA in the stroma of oral malignant and pre-malignant lesions, in association with the expression of p53 and p21 tumor suppressors that were shown previously to be deregulated and/or mutated in stromal fibroblasts of various cancers. The effects of p21 knockdown in SMA expression and cell migration and the mRNA levels of endogenous p21 in fibroblasts co-cultured with cancer cells were also assessed.

Results

We found that both p21 and SMA expression was elevated in the stroma, but not the epithelium, of malignant as compared to pre-malignant lesions. We also noted that the expression of both was positively correlated, implying that SMA expression may be regulated by p21. Consistently with this notion we found that siRNA-mediated p21 suppression resulted in the reduction of SMA levels and also inhibited cell migration.

Conclusion

Our results show that p21 deregulation is associated with the activation of stromal fibroblasts of oral cancers by a mechanism that involves the stimulation of SMA expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. R. Kalluri, M. Zeisberg, Fibroblasts in cancer. Nat. Rev. Cancer 6, 392–401 (2006)

    Article  PubMed  CAS  Google Scholar 

  2. H. Kiaris, G. Trimis, A.G. Papavassiliou, Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy. Curr. Med. Chem. 15, 3062–3067 (2008)

    Article  PubMed  CAS  Google Scholar 

  3. A.P. Sappino, O. Skalli, B. Jackson, W. Schurch, G. Gabbiani, Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707–712 (1988)

    Article  PubMed  CAS  Google Scholar 

  4. L. Ronnov-Jessen, O.W. Petersen, M.J. Bissell, Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69–125 (1996)

    PubMed  CAS  Google Scholar 

  5. B. Hinz, G. Celetta, J.J. Tomasek, G. Gabbiani, C. Chaponnier, Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 12, 2730–2741 (2001)

    PubMed  CAS  Google Scholar 

  6. B. Hinz, G. Gabbiani, Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 14, 538–546 (2003)

    Article  PubMed  CAS  Google Scholar 

  7. A. Desmoulière, C. Guyot, G. Gabbiani, The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int. J. Dev. Biol. 48, 509–517 (2004)

    Article  PubMed  Google Scholar 

  8. G. Trimis, I. Chatzistamou, K. Politi, H. Kiaris, A.G. Papavassiliou, Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Hum. Mol. Genet. 15, 3596–3600 (2008)

    Article  Google Scholar 

  9. J. Bar, R. Feniger-Barish, N. Lukashchuk, H. Shaham, N. Moskovits, N. Goldfinger, D. Simansky, M. Perlman, M. Papa, A. Yosepovich, G. Rechavi, V. Rotter, M. Oren, Cancer cells suppress p53 in adjacent fibroblasts. Oncogene 28, 933–936 (2009)

    Article  PubMed  CAS  Google Scholar 

  10. H. Kiaris, I. Chatzistamou, G. Trimis, M. Frangou-Plemmenou, A. Pafiti-Kondi, A. Kalofoutis, Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res. 65, 1627–1630 (2005)

    Article  PubMed  CAS  Google Scholar 

  11. D. Lafkas, G. Trimis, A.G. Papavassiliou, H. Kiaris, p53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. Int. J. Cancer 123, 967–971 (2008)

    Article  PubMed  CAS  Google Scholar 

  12. F. Moinfar, Y.G. Man, L. Arnould, G.L. Bratthauer, M. Ratschek, F.A. Tavassoli, Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 60, 2562–2566 (2000)

    PubMed  CAS  Google Scholar 

  13. A. Patocs, L. Zhang, Y. Xu, F. Weber, T. Caldes, G.L. Mutter, P. Platzer, C. Eng, Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med. 357, 2543–2551 (2007)

    Article  PubMed  CAS  Google Scholar 

  14. K. Kurose, K. Gilley, S. Matsumoto, P.H. Watson, X.P. Zhou, C. Eng, Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet. 32, 355–357 (2002)

    Article  PubMed  CAS  Google Scholar 

  15. C.C. Liang, A.Y. Park, J.L. Guan, In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329–333 (2007)

    Article  PubMed  CAS  Google Scholar 

  16. I.O. Ng, K.Y. Lam, M. Ng, J.A. Regezi, Expression of p21/waf1 in oral squamous cell carcinomas–correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol. 35, 63–69 (1999)

    Article  PubMed  CAS  Google Scholar 

  17. S. Shintani, Y. Yoshihama, A.R. Emilio, T. Matsumura, Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Anticancer Res. 15, 305–308 (1995)

    PubMed  CAS  Google Scholar 

  18. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 19, 817–825 (1993)

    Article  Google Scholar 

  19. K.A. Comer, P.A. Dennis, L. Armstrong, J.J. Catino, M.B. Kastan, C.C. Kumar, Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene 16, 1299–1308 (1998)

    Article  PubMed  CAS  Google Scholar 

  20. S. Roy, S. Khanna, T. Rink, J. Radtke, W.T. Williams, S. Biswas, R. Schnitt, A.R. Strauch, C.K. Sen, p21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts. Mol. Biol. Cell 18, 4837–4846 (2007)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from ‘KESY’, Ministry of Health, Greece and ‘Kapodistrias’, ELKE, University of Athens.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hippokratis Kiaris.

Additional information

This paper is a reprint from ‘p21/waf1 and smooth-muscle actin α expression in stromal fibroblasts of oral cancers, Ioulia Chatzistamou, Nikolina Dioufa, George Trimis, Alexandra Sklavounou, Christos Kittas, Hippokratis Kiaris and Athanasios G. Papavassiliou’ originally published in Analytical Cellular Pathology/Cellular Oncology, Volume 33, number 1, 2010, pp. 19-26, IOS Press.

An erratum to this article can be found at http://dx.doi.org/10.1007/s13402-011-0063-3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatzistamou, I., Dioufa, N., Trimis, G. et al. p21/waf1 and smooth-muscle actin α expression in stromal fibroblasts of oral cancers. Cell Oncol. 34, 483–488 (2011). https://doi.org/10.1007/s13402-011-0044-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-011-0044-6

Keywords

Navigation